Article Text
LETTER
Osteogenesis imperfecta and intravenous pamidronate
Statistics from Altmetric.com
Osteogenesis imperfecta (OI) is a chronic, disabling condition in which treatment with cyclical intravenous treatment with pamidronate can be useful for symptom relief,1 despite questions about long term safety.2 A recent study3 in this journal showed a decrease in bone turnover and gradual increase in bone density measurements without significant side effects, following such treatment in children affected with OI.
We wish to report our own experience …